Moleculin Biotech reported positive topline efficacy results from its completed U.S. Phase 1B/2 clinical trial of Annamycin for treating soft tissue sarcoma lung ...

| When clinical trial steps are managed separately, the study suffers from compounded delays. Discover proven solutions from ...

We are in an age where medicine is no longer one-size-fits-all; personalised healthcare is changing the diagnosis and ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

Insilico Medicine said results of a clinical trial in China showed positive results in treating idiopathic pulmonary fibrosis ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

PDS Biotechnology ( ($PDSB) ) has shared an update. On June 2, 2025, PDS Biotechnology Corporation announced the publication of three Versamune® ...

KFSHRC accounts for 52.4% of all active clinical trials in Saudi Arabia.

The Association for Diagnostics and Laboratory Medicine (ADLM) has awarded Tulane University research scientist Tony Hu, PhD, ...

Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to ...